Paclitaxel and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Paclitaxel (paclitaxel), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Cyclophosphamide, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Uveitis when taking Paclitaxel. It is created by eHealthMe based on reports of 85,850 people who have side effects when taking Paclitaxel from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,532 conditions by eHealthMe. Check the latest studies of Uveitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

85,850 people reported to have side effects when taking Paclitaxel.
Among them, 36 people (0.04%) have Uveitis.

Among these 36 people:

How long have people been on Paclitaxel when they have Uveitis? *

What is the gender of people who have Uveitis when taking Paclitaxel? *

female: 90 %
male: 10 %

What is the age of people who have Uveitis when taking Paclitaxel? *

What are other drugs people take besides Paclitaxel? *

Cyclophosphamide: 12 people, 33.33%
Carboplatin: 6 people, 16.67%
Femara: 4 people, 11.11%
Opdivo: 3 people, 8.33%
Herceptin: 3 people, 8.33%
Chloramphenicol: 2 people, 5.56%
Epirubicin Hydrochloride: 2 people, 5.56%
Yervoy: 2 people, 5.56%
Keytruda: 2 people, 5.56%
Zofran: 2 people, 5.56%

What are other side effects people have besides Uveitis? *

Retinopathy (acute damage to the retina of the eye): 8 people, 22.22%
Neuropathy Peripheral (surface nerve damage): 6 people, 16.67%
Retinal Vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels): 5 people, 13.89%
Hyperkeratosis (thickening of the outer layer of the skin): 4 people, 11.11%
Emotional Distress: 4 people, 11.11%
Nail Abnormalities (abnormal nail): 4 people, 11.11%
Optic Neuritis (optic nerve inflammation): 4 people, 11.11%
Vitritis (inflammation of the vitreous humour of the eye): 3 people, 8.33%
Drug Ineffective: 3 people, 8.33%
Onychomadesis (a periodic idiopathic shedding of the nails): 3 people, 8.33%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 5 people, 13.89%
High Blood Pressure: 4 people, 11.11%
Stress And Anxiety: 2 people, 5.56%
Retinal Vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels): 2 people, 5.56%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 2 people, 5.56%
Nausea (feeling of having an urge to vomit): 2 people, 5.56%
Cataract (clouding of the lens inside the eye): 2 people, 5.56%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 2.78%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 2.78%
Rashes (redness): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paclitaxel:

Paclitaxel (85,928 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,532 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Paclitaxel) and Paclitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.